Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The Current Genomic and Molecular Landscape of Philadelphia-like Acute Lymphoblastic Leukemia
Parveen Shiraz, Kimberly J. Payne, Lori Muffly
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 6, pp. 2193-2193
Open Access | Times Cited: 37

Showing 1-25 of 37 citing articles:

A Summary of the Inaugural WHO Classification of Pediatric Tumors: Transitioning from the Optical into the Molecular Era
Stefan M. Pfister, Miguel Reyes‐Múgica, John K. C. Chan, et al.
Cancer Discovery (2021) Vol. 12, Iss. 2, pp. 331-355
Open Access | Times Cited: 134
The Role of Curcumin in Cancer: A Focus on the PI3K/Akt Pathway
Vasiliki Zoi, Athanassios P. Kyritsis, Vasiliki Galani, et al.
Cancers (2024) Vol. 16, Iss. 8, pp. 1554-1554
Open Access | Times Cited: 27
Targeted Therapy in the Treatment of Pediatric Acute Lymphoblastic Leukemia—Therapy and Toxicity Mechanisms
Monika Lejman, Kinga Kuśmierczuk, Kinga Bednarz, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 18, pp. 9827-9827
Open Access | Times Cited: 27
JAK2 Alterations in Acute Lymphoblastic Leukemia: Molecular Insights for Superior Precision Medicine Strategies
Charlotte E. J. Downes, Barbara J. McClure, Daniel P. McDougal, et al.
Frontiers in Cell and Developmental Biology (2022) Vol. 10
Open Access | Times Cited: 20
Genomic and proteomic characterization of Philadelphia‐like B‐lineage acute lymphoblastic leukemia: A report of Indian patients
Dikshat Gopal Gupta, Neelam Varma, Ashish Kumar, et al.
Cancer (2023) Vol. 129, Iss. 8, pp. 1217-1226
Closed Access | Times Cited: 12
Definition and Prognostic Value of Ph-like and IKZF1plus Status in Children With Down Syndrome and B-cell Precursor Acute Lymphoblastic Leukemia
Chiara Palmi, Silvia Bresolin, Stefanie V. Junk, et al.
HemaSphere (2023) Vol. 7, Iss. 6, pp. e892-e892
Open Access | Times Cited: 12
Integrative Insights into Philadelphia-like B-Cell Acute Lymphoblastic Leukemia: A Genetic and Molecular Landscape
S E Chuang, Apple H. Chu, Rodrigo Hurtado, et al.
Diagnostics (2025) Vol. 15, Iss. 3, pp. 385-385
Open Access
Bridging the Gap: Cost-Effective Strategies for Detecting Ph-Like B-Lineage ALL in Resource-Limited Settings
Dikshat Gopal Gupta, Monika, Neelam Varma
Molecular Diagnosis & Therapy (2025)
Closed Access
PAX5 fusion genes are frequent in poor risk childhood acute lymphoblastic leukaemia and can be targeted with BIBF1120
Grazia Fazio, Silvia Bresolin, Daniela Silvestri, et al.
EBioMedicine (2022) Vol. 83, pp. 104224-104224
Open Access | Times Cited: 17
Combination efficacy of ruxolitinib with standard-of-care drugs in CRLF2-rearranged Ph-like acute lymphoblastic leukemia
Julia Böhm, Keith C.S. Sia, Connor Jones, et al.
Leukemia (2021) Vol. 35, Iss. 11, pp. 3101-3112
Closed Access | Times Cited: 23
‘Evaluation of adverse prognostic gene alterations & MRD positivity in BCR::ABL1-like B-lineage acute lymphoblastic leukaemia patients, in a resource-constrained setting
Dikshat Gopal Gupta, Neelam Varma, Sreejesh Sreedharanunni, et al.
British Journal of Cancer (2023) Vol. 129, Iss. 1, pp. 143-152
Closed Access | Times Cited: 8
Philadelphia-like acute lymphoblastic leukemia: the journey from molecular background to the role of bone marrow transplant—review article
Reham Alghandour, Doaa H. Sakr, Yasmine Shaaban
Annals of Hematology (2023) Vol. 102, Iss. 6, pp. 1287-1300
Open Access | Times Cited: 7
B-ALL Complexity: Is Targeted Therapy Still A Valuable Approach for Pediatric Patients?
Stefano Ratti, Annalisa Lonetti, Matilde Y. Follo, et al.
Cancers (2020) Vol. 12, Iss. 12, pp. 3498-3498
Open Access | Times Cited: 18
Philadelphia chromosome-like acute lymphoblastic leukemia with concomitant rearrangements of CRLF2 and ABL1: a pediatric case report
Guoqian He, Yupeng Lei, Duo-wen Huang, et al.
BMC Pediatrics (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 2
Hematological, clinical, immunophenotypic characterization, and treatment outcomes of prognostically significant genetic subtypes of B‐lineage acute lymphoblastic leukemia: A report of 1021 patients from India
Dikshat Gopal Gupta, Neelam Varma, Praveen Sharma, et al.
Cancer (2023) Vol. 129, Iss. 21, pp. 3390-3404
Closed Access | Times Cited: 5
A surrogate molecular approach for the detection of Philadelphia chromosome–like B‐acute lymphoblastic leukemia
Dikshat Gopal Gupta, Neelam Varma, Sarki A. Abdulkadir, et al.
Cancer (2023) Vol. 130, Iss. 5, pp. 713-726
Open Access | Times Cited: 5
The Role of Proteasome Inhibitors in Treating Acute Lymphoblastic Leukaemia
Chun‐Fung Sin, Pui-hei Marcus Man
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 12
PHi-RACE: PGIMER in-house rapid & cost effective classifier for the detection of BCR-ABL1-like acute lymphoblastic leukaemia in Indian patients
Dikshat Gopal Gupta, Neelam Varma, Ashish Kumar, et al.
Leukemia & lymphoma/Leukemia and lymphoma (2021) Vol. 63, Iss. 3, pp. 633-643
Closed Access | Times Cited: 11
Judicious use of precise fluorescence in situ hybridisation panels guided by population prevalence may assist pragmatic detection of clinically targetable Philadelphia chromosome-like acute lymphoblastic leukaemia fusions: a systematic review
Jane Thompson, Geoffrey N. Thompson, Deborah L. White, et al.
Pathology (2024)
Open Access | Times Cited: 1
BCL6 inhibition ameliorates resistance to ruxolitinib in <i>CRLF2</i>-rearranged acute lymphoblastic leukemia
Shinobu Tsuzuki, Takahiko Yasuda, Hiroaki Goto, et al.
Haematologica (2022) Vol. 108, Iss. 2, pp. 394-408
Open Access | Times Cited: 7
Diversity upon diversity: linking DNA double-strand break repair to blood cancer health disparities
Jason N. Sterrenberg, Melissa L. Folkerts, Valeria Rangel, et al.
Trends in cancer (2022) Vol. 8, Iss. 4, pp. 328-343
Open Access | Times Cited: 6
Genomic Analyses of Pediatric Acute Lymphoblastic Leukemia Ph+ and Ph-Like—Recent Progress in Treatment
Agnieszka Kaczmarska, Patrycja Śliwa-Tytko, Joanna Zawitkowska, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 12, pp. 6411-6411
Open Access | Times Cited: 8
Identification and validation of the optimal reference genes for standardizing the gene expression profiling diagnostic panel of Ph-like B-lineage acute lymphoblastic leukemia
Dikshat Gopal Gupta, Neelam Varma, Sarki A. Abdulkadir, et al.
Clinical and Experimental Medicine (2023) Vol. 23, Iss. 8, pp. 4539-4551
Closed Access | Times Cited: 3
Optimal approach to the treatment of young adults with acute lymphoblastic leukemia in 2020
Cecilie Utke Rank, Kjeld Schmiegelow
Seminars in Hematology (2020) Vol. 57, Iss. 3, pp. 102-114
Open Access | Times Cited: 7
Prognostic significance of CRLF2 overexpression and JAK2 mutation in Egyptian pediatric patients with B-precursor acute lymphoblastic leukemia
Naglaa M. Hassan, Mona S. Abdellateif, Enas Radwan, et al.
Clinical Lymphoma Myeloma & Leukemia (2021) Vol. 22, Iss. 6, pp. e376-e385
Closed Access | Times Cited: 7
Page 1 - Next Page

Scroll to top